Literature DB >> 15656820

Cannabis arteritis.

P Combemale1, T Consort, L Denis-Thelis, J-L Estival, M Dupin, J Kanitakis.   

Abstract

The main causes of arteriopathy in young patients include drugs, metabolic diseases, pseudoxanthoma elasticum and Buerger's disease. Arteritis due to Cannabis indica was first reported in 1960, and the role of this drug as a risk factor for arteritis was confirmed in several subsequent publications. A 38-year-old smoker with no previous contributory medical history except for long-standing cannabis abuse developed a dry necrotic lesion of the left big toe. Imaging examinations revealed proximal arteriopathy of the lower limbs that predominated on the left side. He had no atherogenic or thrombogenic risk factors, and no signs of pseudoxanthoma elasticum were found. Remarkably, the development of arteritis paralleled cannabis abuse. The course was slowly favourable after weaning from the drug, vasodilator treatment and hyperbaric oxygen therapy. Despite some subtle clinical differences (more proximal than distal involvement), cannabis arteritis may be considered as a particular form of Buerger's disease, where cannabis, along with tobacco, seems to cause arterial lesions. Along with the noxious effects of cannabis on vessels, a role for contaminating arsenic is also possible. Cannabis arteritis is not widely known, but may prove not to be so rare if one considers consumption of cannabis besides that of tobacco.

Entities:  

Mesh:

Year:  2005        PMID: 15656820     DOI: 10.1111/j.1365-2133.2005.06340.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  13 in total

1.  Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects.

Authors:  Laura M Dryburgh; Nanthi S Bolan; Christopher P L Grof; Peter Galettis; Jennifer Schneider; Catherine J Lucas; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2018-08-01       Impact factor: 4.335

2.  Consumption of cannabis and cocaine: correct mix for arterial occlusions.

Authors:  Priyanka Sharma; Susana Ramirez-Florez
Journal:  BMJ Case Rep       Date:  2009-04-28

3.  Etiopathogenesis, clinical diagnosis and treatment of thromboangiitis obliterans - current practices.

Authors:  Edwaldo Edner Joviliano; Renata Dellalibera-Joviliano; Marcelo Dalio; Paulo Rb Evora; Carlos E Piccinato
Journal:  Int J Angiol       Date:  2009

4.  Cannabis-related hospitalizations: unexpected serious events identified through hospital databases.

Authors:  Emilie Jouanjus; Florence Leymarie; Marie Tubery; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

5.  Cannabis arteritis: ever more important to consider.

Authors:  Rui Pedro Santos; Cristina Isabel Pinho Resende; Ana Paula Vieira; Celeste Brito
Journal:  BMJ Case Rep       Date:  2017-03-13

Review 6.  Nonatherosclerotic PAD: Approach to Exertional Pain in the Lower Extremities.

Authors:  Ari J Mintz; Ido Weinberg
Journal:  Curr Cardiol Rep       Date:  2015-08       Impact factor: 2.931

Review 7.  Drugs of Misuse: Focus on Vascular Dysfunction.

Authors:  Holly R Middlekauff; Ziva D Cooper; Sasha B Strauss
Journal:  Can J Cardiol       Date:  2022-04-22       Impact factor: 6.614

8.  Cannabis arteritis: A case report and brief review of the literature.

Authors:  Youssef Banana; Husam Bashir; Sara Boukabous; Abdellah Rezziki; Adnane Benzirar; Omar El Mahi
Journal:  Ann Med Surg (Lond)       Date:  2022-03-28

9.  Buerger's disease (thromboangiitis obliterans): clinical features and assessment by colour duplex ultrasound.

Authors:  Kathryn Busch
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

10.  Cannabis arteritis.

Authors:  Naoual El Omri; Rachid Eljaoudi; Fadwa Mekouar; Mohammed Jira; Youssef Sekkach; Taoufik Amezyane; Driss Ghafir
Journal:  Pan Afr Med J       Date:  2017-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.